Close

Notable Analyst Rating Changes 11/11: (LSCC) (GNW) (DNDN) Upgraded; (CAG) (BRLI) (FSLR) Downgraded Nov 11, 2011 11:26AM
Jefferies Raises Expectations on Seattle Genetics (SGEN) Adcetris Sales Following Talks with EAP Centers Oct 12, 2011 08:57AM
Jefferies Ups PT on Seattle Genetics (SGEN) to $25 Following Adcetris Call; Adjusts Numbers, Outlook Aug 23, 2011 09:50AM
Jefferies Comments on FDA Approval of Seattle Genetics (SGEN) Adcetris, Better-Than-Expected Aug 22, 2011 08:14AM
Jefferies Boosts PT on Seattle Genetics (SGEN) Following FDA Panel Vote; Is Buyer on Weakness Jul 15, 2011 10:03AM


Jun 6, 2011 07:25AM Jefferies Reiterates Bullish Stance On Seattle Genetics (SGEN) Related To Eventual Adcentris Label
Feb 17, 2011 08:12AM Jefferies Starts Seattle Genetics (SGEN) at Buy, Price Target $22
Feb 1, 2011 04:40PM Seattle Genetics (SGEN) To Offer Common Shares
Nov 1, 2010 11:17AM Notable Analyst Rating Changes 11/01: PFE, EGO, INTC, ACI Upgraded; ANH, SPLS, SGEN, AXL Downgraded
Sep 29, 2010 08:16AM Jefferies Starts Seattle Genetics (SGEN) at Buy
Aug 31, 2010 10:20AM Notable Analyst Rating Changes 08/31: GPS, ANF, BMY, UBS Upgraded; HPQ, DGIT, RAX, POT Downgraded
Apr 24, 2009 10:00AM Morning Movers 4/24: DDR, SUMT, F, CHRT, ZGEN Higher; UCBH, IBKR, BLUD, IBCP, COLM Lower